429 related articles for article (PubMed ID: 19125911)
1. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
Almeida L; Neves M; Cardoso E; Melo A
J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
[TBL] [Abstract][Full Text] [Related]
2. Interferon beta-1A: new preparation. A short-term impact on the course of multiple sclerosis.
Prescrire Int; 1998 Oct; 7(37):142-3. PubMed ID: 10915418
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
Duchini A
Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
[No Abstract] [Full Text] [Related]
4. Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.
Castelli-Haley J; Oleen-Burkey M; Lage MJ; Johnson KP
Adv Ther; 2008 Jul; 25(7):658-73. PubMed ID: 18641926
[TBL] [Abstract][Full Text] [Related]
5. [Interferon therapy of multiple sclerosis].
Jensen D
Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
[TBL] [Abstract][Full Text] [Related]
6. Growth dynamics of meningiomas in patients with multiple sclerosis treated with interferon: report of two cases.
Batay F; Al-Mefty O
Acta Neurochir (Wien); 2002 Apr; 144(4):365-8. PubMed ID: 12021883
[TBL] [Abstract][Full Text] [Related]
7. Cotton wool spots associated with interferon beta-1 alpha therapy.
Longmuir R; Lee AG; Rouleau J
Semin Ophthalmol; 2007; 22(1):49-53. PubMed ID: 17366120
[TBL] [Abstract][Full Text] [Related]
8. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
Mikaeloff Y; Moreau T; Debouverie M; Pelletier J; Lebrun C; Gout O; Pedespan JM; Van Hulle C; Vermersch P; Ponsot G
J Pediatr; 2001 Sep; 139(3):443-6. PubMed ID: 11562627
[TBL] [Abstract][Full Text] [Related]
9. [Activation of psoriasis in patients undergoing treatment with interferon-beta].
Navne JE; Hedegaard U; Bygum A
Ugeskr Laeger; 2005 Aug; 167(32):2903-4. PubMed ID: 16109199
[TBL] [Abstract][Full Text] [Related]
10. Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.
Serarslan G; Okuyucu E; Melek I; Hakverdi S; Duman T
Mult Scler; 2008 Mar; 14(2):259-61. PubMed ID: 18337427
[TBL] [Abstract][Full Text] [Related]
11. Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta.
Strueby L; Nair B; Kirk A; Taylor-Gjevre RM
Scand J Rheumatol; 2005; 34(6):485-8. PubMed ID: 16393774
[TBL] [Abstract][Full Text] [Related]
12. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
[TBL] [Abstract][Full Text] [Related]
13. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
Nakamura Y; Kawachi Y; Furuta J; Otsuka F
Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
[TBL] [Abstract][Full Text] [Related]
14. Fixed drug eruption with interferon-beta-1b.
Tai YJ; Tam M
Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
[TBL] [Abstract][Full Text] [Related]
15. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
Kocer B; Nazliel B; Oztas M; Batur HZ
Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
[No Abstract] [Full Text] [Related]
16. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis].
Sommer S; Sablon JC; Zaoui M; Rozot P; Hosni A
J Fr Ophtalmol; 2001 May; 24(5):509-12. PubMed ID: 11397988
[TBL] [Abstract][Full Text] [Related]
17. [Subacute cutaneous lupus erythematosus and interferon beta-1 a].
Schmutz J; Barbaud A; Tréchot P
Ann Dermatol Venereol; 2000 Feb; 127(2):237. PubMed ID: 10739993
[No Abstract] [Full Text] [Related]
18. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
Ball NJ; Cowan BJ; Hashimoto SA
J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
[TBL] [Abstract][Full Text] [Related]
19. Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
Sorensen PS; Koch-Henriksen N; Ross C; Clemmesen KM; Bendtzen K;
Neurology; 2005 Jul; 65(1):33-9. PubMed ID: 15888603
[TBL] [Abstract][Full Text] [Related]
20. Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a.
Schwid SR; Decker MD; Lopez-Bresnahan M;
Neurology; 2005 Dec; 65(12):1964-6. PubMed ID: 16380621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
